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ABSTRACT
Objective: We undertook the present study to attempt to apply clinical indicators predictive of cervical
infection in nongravid populations with either Neisseria gonorrhoeae or Chlamydia trachomatis to
our pregnant population and to determine the significance of the clinical diagnosis of "cervicitis."
Methods: A retrospective chart review of all pregnant women with a final diagnosis of cervicitis
who were seen in the Medical College of Virginia obstetrical emergency room was performed during
the period of September 1991 to December 1992.
Results: Given the diagnosis of cervicitis in our emergency department, we found that the clinical
examination predicted cervical infection with N. gonorrhoeae or C. trachomatis in only 20% of the
pregnant women. Gravidas with chlamydial infections were younger (20.1 +- 3.7 years) compared
with gravidas not infected (23.2 +_ 5.4 years) (P < 0.0001). They were also more likely to have a
diagnosis of lower urinary-tract infection [relative risk (RR) 2.89, 95% confidence interval (CI) 1.425.85].
Conclusions: The clinical indicators of cervical infection with C. trachomatis and N. gonorrhoeae
were unreliable. (C) 1996 Wiley-Liss, Inc.
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creening populations of nongravid women reveals that several variables are predictive of Chlamydia tracaomatis infections: age younger than 24
years, intercourse with a new partner in the preceding 2 months, purulent or mucopurulent cervical
exudate, endocervical bleeding induced by swabbing, and lack of contraception or use of a nonbarrier
method. Several studies in developing countries
aimed at identifying those variables that would support the clinical diagnosis of chlamydial or gonococcal infections in pregnant women have produced
mixed results, z’3
To date, there have been no published studies
in industrialized countries to examine the value of
clinical indicators in predicting cervical infections

in pregnant women. We undertook the present
study to attempt to apply clinical indicators predictive of cervical infections with either Neisseria
gonorrhoeae or C. tracaomatis in nongravid populations to our pregnant population and to determine
the significance of the clinical diagnosis of "cervicitis."

SUBJECTS AND METHODS
A retrospective chart review was carried

of all
pregnant women seen in the Medical College of
Virginia obstetrical emergency room with a final
diagnosis of cervicitis during the period of September 1991 to December 1992. This time was chosen
as a convenience sample to include approximately
out
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250 women. Cervicitis was defined as the presence
of endocervical mucopus, leukorrhea (>10 WBCs/
hpf), or cervical friability (cervical bleeding induced
with a swab). Lower urinary-tract infection, as diagnosed by urinalysis, was defined as the presence of
leukocytes, bacteria, nitrites, or erythrocytes in the
absence of large numbers of epithelial cells on a
clean-catch or catheterized urine specimen. All
women were interviewed and examined by either
an obstetrical resident or an obstetrics and gynecology nurse practitioner. The data collected on all
patients included age, race, estimated gestational
age, gravidity, parity, presenting complaints, and
history of sexually transmitted diseases (STDs) including chlamydial and gonococcal infections. In
addition, information was obtained regarding the
presence of endocervical mucopus or cervical friability, direct smear of endocervical secretions for
WBCs, results of wet mount examination of pooled
vaginal fluid for the presence of WBCs and Trichomonas vaginalis, and any other diagnoses assigned
at the time of discharge.
Each patient underwent a speculum examination with collection of endocervical specimens for
N. gonorrhoeae culture and for chlamydial antigen
detection (Chlamydiazyme, Abbott Laboratories,
Chicago, IL). Each endocervical culture for N.
gonorrhoeae was inoculated onto Martin Lewis
Transgrow medium (Becton Dickinson, Cockeysville, MD) and then incubated at 35C in a 5%
carbon dioxide atmosphere. A positive culture was
presumptively identified by a Gram’s stain of the
colonies and a positive oxidase test. The endocervical specimens for C. trachomatis were collected using
the STD-EZE collection kit (Abbott Laboratories).
The presence of the chlamydia antigen was determined in the clinical microbiology laboratory using
the Chlamydiazyme enzyme-linked immunosorbent assay (ELISA) test following the manufactur-

er’s directions.
A statistical analysis was performed utilizing the
Student’s t-test for continuous variables. The categorical variables were analyzed utilizing the chisquare or Fisher exact test when appropriate.
P < 0.05 (using a two-tailed statistical test) was considered significant.

RESULTS
Two hundred fifty-five pregnant women with a diagnosis of cervicitis were seen between September

1991 and December 1992. The results of gonorrhea
and chlamydia testing were available for 251. Three
of the samples obtained for chlamydia testing read
as "inconclusive" were not included, leaving 248
patients for analysis. Ten (4%) women tested positive for N. gonorrhoeae and 42 (17%) tested positive
for C. trachomatis. Of those infected with gonorrhea,
3 (30%) were coinfected with chlamydia. Because
the clinical diagnosis of cervicitis was so poorly predictive of the presence of either N. gonorrhoeae or
C. trachomatis, we then examined the individual
clinical findings to determine whether any one was
a better predictor of the presence of infection in
pregnant women. Of the patients with gonococcal
infections, 40% had cervical friability, 50% had endocervical mucopus, and 80% had leukorrhea. In
those with chlamydial infections, friability was
noted in 55%, endocervical mucopus in 55%, and
leukorrhea in 88%. Friability was present in 127
patients, of whom 4 (3%) tested positive for N.
gonorrhoeae and 23 (18%) tested positive for C. trachomatis. Mucopus was present in 119 patients, of
whom 5 (4%) tested positive for N. gonorrhoeae and
23 (19%) tested positive for C. trachomatis. Leukorrhea was seen in 211 patients, of whom 8 (4%)
tested positive for N. gonorrhoeae and 37 (17%)
tested positive for C. trachomatis.
The mean age of patients having a positive Chlamydiazyme was significantly younger compared
with those having a negative test: 20.1 + 3.7 vs.
23.2 + 5.4 years (P < 0.0001) (Table 1). Thirty-six
women (86%)with C. trachomatis were younger than
24 years. There were no significant differences between groups in gestational age, gravidity, parity,
history of STDs, complaints of dysuria, abdominopelvic pain, vaginal bleeding, or vaginal discharge
(Tables 1, 2). There were also no statistical differences in the incidence of cervical friability, endocervical mucopus, or WBCs or T. vaginalis on wet
mount (Table 3). There was an association between
the presence of a positive Chlamydiazyme test and
a final discharge diagnosis of lower urinary-tract
infection [P 0.006; relative risk (RR) 2.89, 95%
confidence interval (CI) 1.42-5.85].

DISCUSSION
STDs are common complications of pregnancy, particularly in indigent urban populations, with N. gonorrhoeae and C. trachomatis being among the most
common organisms encountered. C. trachomatis is
INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY
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TABLE I. Comparison of characteristics of pregnant women with cervicitis, with and without gonoccocal or
chlamydial infection

__

Negative

Characteristic

(N

(N

Age (years)
EGA (weeks)

22.2 5.0
18.7 _+ 11.3
3.3 1.8
1.6 1.4
0.7 +_ I.I

Gravidity
Parity
Abortus
aEGA

10)

estimated gestational age; NS

not

Positive

238)

P

5.2
9.7
2.0
1.5

NS
NS
NS
NS
NS

22.7 _+
17.9
3.2
1.4
0.8-+

_

C. trachomatis

N. gonorrhoeae

Positive

I.I

Negative

42)

(N

(N

206)

23.2 +_ 5.4
18.0 9.8
3.2 1.9
1.5 1.5

20.1 +_ 3.7
17.6 9.8
3.0 +__ 2.3
1.3 _+ 1.4
0.7_ 1.4

0.8_

<0.0001

NS
NS
NS
NS

I.I

significant.

TABLE 2. Comparison of symptoms of pregnant women with

cervicitis, with and without gonoccocal or

chlamydial infection
N. gonorrhoeae
Positive

Negative

Symptom

(N

(N

Bleeding
Discharge
Dysuria

2
4
2
6

Pain

aNS

not

10)
(20%)
(40%)
(20%)
(60%)

112
77
17
137

Positive

238)
(47%)
(32%)
(7%)
(57%)

P

(N

42)

NS
NS
NS
NS

17
14
5
25

(40%)
(33%)
(12%)
(59%)

C. trachomatis
Negative

206)

(N
97
67
14
118

(47%)
(33%)
(7%)
(57%)

P
NS
NS
NS
NS

significant.

TABLE 3. Comparison of physical findings of pregnant women with

cervicitis, with and without

gonoccocal or

chlamydial infection
Positive

Physical finding
Friability

Mucopus
Leukorrhea
Trichomonas

aNS

not

(N

10)

4 (40%)
5 (50%)
8 (80%)

(10%)

N. gonorrhoeae
Negative

(N
123
104
203
20

238)
(52%)
(44%)
(85%)
(8%)

(N

42)

NS
NS
NS
NS

23
23
37
3

(55%)
(55%)
(88%)
(7%)

(N
104
86
174
18

206)
(50%)
(42%)
(84%)
(9%)

P
NS
NS
NS
NS

significant.

the most common sexually transmitted bacterial microorganism, with a prevalence from 2 to 37% in
pregnant women. N. gonorrhoeae was found in approximately 4% of pregnant patients in a study at
Parkland Memorial Hospital in Dallas, TX; approximately 46% of gravid women with gonococcal infections were coinfected with C. trachomatis.
Braddick et al. examined pregnant women in
an antenatal clinic in Nairobi, Kenya, and found
that the prevalence of C. trachomatis and N. gonorrhoeae was 8% and 10%, respectively. The presence
of clinical cervicitis (defined as the presence of either endocervical mucopus or induced cervical
186

Positive

P

C. trachomatis
Negative
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bleeding) and having more than one sexual partner
during the pregnancy were independently predictive of a true cervical infection, with sensitivities
and specificities of 61% and 79% and 68% and 93%,
respectively. The combination of more than one
sexual partner during the pregnancy and the clinical
diagnosis of cervicitis raised the specificity to 86%;
however, the sensitivity dropped to 11%.
Vuylsteke and colleagues studied 1,160 pregnant women presenting to an antenatal health clinic
for initial prenatal care in Kinasha, Zaire. Those
patients who were included in the study had symptoms of vaginal discharge or abdominal pain. Nearly

CLINICAL INDICATORS OF CER VICITIS IN PREGNANCY

2% of the women tested positive for N. gonorrhoeae
and 5.2% tested positive for C. trachomatis. The
factors significantly associated with cervical infections in pregnant women included younger age
(mean 22.3 years), single marital status, having had
more than one sexual partner in the preceding 12
months, a vaginal discharge, >10 WBCs/hpf in a
cervical or vaginal specimen, and a positive leukocyte-esterase dipstick when testing a midstream
urine sample. However, no single symptom or physical sign reached an acceptable level of sensitivity
and specificity to be predictive of cervical infections. A scoring system based on marital status, maternal age, symptoms of vaginal discharge or abdominal pain, and leukocyte-esterase dipstick of urine
was formulated and used in a diagnostic model for
the prediction of cervical infections. In their population, they were able to predict infections with a
sensitivity of 72% and specificity of 74%; however,
the positive predictive value reached only 16%.
Of the variables shown to be associated with
cervical C. trachomatis infections in nongravid
women, only the maternal age was significantly different in our study. We were unable to correlate
other clinical signs and symptoms shown to be associated with a positive gonococcal or chlamydial test
in nongravid women. Our study revealed no signifiassociation between "clinical cervicitis" in
pregnancy and a true cervical infection.
There was a correlation between the diagnosis
of lower urinary-tract infection and a subsequent
positive test for C. trachomatis. Gravid women with
this diagnosis were twice as likely to have a cervical chlamydial infection than those without. This
finding probably reflects the presence of chlamydia
urethritis in these patients and indicates that clinicians should be suspicious of a chlamydial cervical infection in the setting of a lower urinary-tract
infection as diagnosed by urinalysis in a pregnant

cant

woman.

The ability to clinically diagnose cervical infections due to N. gonorrhoeae or C. trachomatis may
enable clinicians to reduce the maternal and neonatal sequelae of these infections. Our patient population, being primarily indigent, relied heavily upon
the emergency room for health care. Therefore,
we have chosen to treat all presumptive cases of
gonococcal or chlamydial cervical infections (cervicitis), assuming that we may not be able to relay a
positive test result and offer treatment once the

JACKSON E T AL.

patient has been discharged from the emergency
department. The present study shows that the clinical diagnosis of mucopurulent cervicitis is a poor
predictor of endocervical infection with N. gonorrhoeae or C. trachomatis, with 10/248 (4%) cases positive for N. gonorrhoeae, and 42/248 (17%) positive
for C. trachomatis, for a total of 49/248 (20%) positive
for one or the organism. It appears that we overtreat
a large number of patients (80%), exposing them
to unnecessary antibiotic therapy. The Centers for
Disease Control (CDC) recommends the treatment
of mucopurulent cervicitis based on the results of
testing for C. trachomatis and N. gonorrhoeae, but
cautions that empirical treatment should be given
if the likelihood of infection with either of these
organisms is high or the patient is not likely to
return for treatment.
From the data evaluated, we should have a
higher index of suspicion for an endocervical chlamydial infection in pregnancy if the patient is
younger than 24 years or has a urinalysis consistent
with a lower urinary-tract infection in the setting
of clinical cervicitis. There were no identifiable reliable predictors for cervical gonococcal infections.
Finally, we should attempt to improve our clinical
prediction of gonococcal or chlamydial cervical infections in pregnant women presenting to our emergency department.
As this study evaluated an urban, indigent group
of patients, who are at higher risk of cervical infections, this information is only applicable to similar
patient populations. By the inclusion criteria for the
study, we preselected a group of patients with an
inherently higher risk for gonococcal and chlamydial cervical infections. As there were relatively small
numbers of patients with positive test results, a
subgroup analysis of the data introduces the possibility of a type II error. A larger sample size would
help to alleviate this problem and improve the
power of the study. A prospective examination of
pregnant women with and without the diagnosis of
endocervicitis utilizing cultures for C. trachomatis
and N. gonorrhoeae may identify predictors useful
for the clinical identification of a true gonococcal
or chlamydial endocervical infection in pregnancy.
In summary, the clinical indicators of cervical
infection with C. trachomatis and N. gonorrhoeae were
unreliable in our patient population. In light of
these findings, continued screening of this patient
population for these STDs is recommended.
INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY
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